$5.87
0.05 | 0.86%
0.05 | 0.86%
Today's Range:
5.79 -
5.89
ARQL Avg. Daily Volume:
554,500
05/25/12 - 4:00 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 5.87 |
| 52 Week High | 8.32 |
| 52 Week Low | 3.98 |
| Avg. Daily Vol. (Mil) | 0.55 |
| Beta (3 year) | 1.32 |
| Share Related Items | |
| Mkt Cap (Mil) | 365.12 |
| Shares Out (Mil) | 62.20 |
| Float (Mil) | 40.08 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.50 |
| Current Ratio | 1.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.06 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 8.61 |
| Price/Book | 13.23 |
| Price/Cash Flow | -30.50 |
| Per Share Data | |
| Earnings | -0.24 |
| Sales | 0.68 |
| Book Value | 0.44 |
| Cash Flow | -0.19 |
| Business Summary | |
|---|---|
| ArQule, Inc. is a clinical-stage biotechnology company, which is engaged in the research and development of innovative cancer therapeutics directed toward molecular targets that play critical roles in the development of human cancers. | |
| General Information | |
| 19 Presidential Way
Woburn, MA 01801 |
|
| www.arqule.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 103 | |
| CEO: Paolo Pucci | |
| Short Interest | |
| Current Month (Mil) | 2.70 |
| Previous Month (Mil) | 2.30 |
| Short Interest Ratio (Days) | 5.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -12.80 |
| Return on Investments | -49.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -31.90 |
| Profit Margin | -32.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet